HCA (NYSE: HCA), which operates 169 hospitals and 116 freestanding
surgery centers in 20 states and the United Kingdom, announced today the
signing of an agreement to purchase Mobile Heartbeat, a leading
developer of applications for smartphones to improve clinical workflow
and team communications. Mobile Heartbeat technology solutions
consolidate clinical communications, including alarms and notifications,
patient information and lab data, secure texting, voice and photography.
HCA recently completed a successful pilot of Mobile Heartbeat’s CURE™
(Clinical Urgent Response) technology for its iMobile Project, an
initiative to implement smartphone-based critical care team
communications. Today, HCA is launching Mobile Heartbeat’s CURE
technology in 21 hospitals across the country with plans to implement
the technology enterprise-wide.
“Mobile Heartbeat is an innovator that is keenly focused on meeting the
mobile technology needs of clinicians,” said Dr. Jonathan Perlin, HCA’s
chief medical officer and president of the Clinical Services Group.
“This acquisition will enhance our ability to work closely with Mobile
Heartbeat as we continue to create and refine technology solutions to
improve clinical workflows and provide secure communications that foster
better patient care.”
Following the completion of the transaction, Mobile Heartbeat’s current
chief executive officer Ron Remy will serve as CEO of the organization
which will operate as an indirect, wholly owned subsidiary of HCA.
Mobile Heartbeat’s team will continue to serve the company’s clients and
market its products to leading healthcare organizations from the
company’s location in Massachusetts.
“We’ve worked closely with HCA for several years to better understand
the challenges clinicians face and to enhance our applications to meet
their needs,” said Remy. “Joining HCA will help us serve our current and
future customers through a closer collaboration with one of the leading
healthcare providers in the world. HCA’s leadership will be instrumental
as we continue to develop improved solutions for secure clinical
communications.”
HCA expects to complete the transaction before the end of the year.
Terms of the agreement are not being disclosed.
Founded in 2009, Mobile Heartbeat provides a highly efficient,
patient-specific, clinical team collaboration solution. For more
information, visit www.mobileheartbeat.com.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the federal securities laws, which involve risks and
uncertainties. Forward-looking statements include statements that do not
relate solely to historical or current facts. Forward-looking statements
can be identified by the use of words like “may,” “believe,” “will,”
“expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or
“continue.” These forward-looking statements are based on our current
plans and expectations and are subject to a number of known and unknown
uncertainties and risks, many of which are beyond our control, which
could significantly affect current plans and expectations and our future
financial position and results of operations. These factors include, but
are not limited to, the ability to consummate and realize the benefits
of the proposed acquisition as well as the risk factors described in our
annual report on Form 10-K for the year ended December 31, 2015 and our
other filings with the Securities and Exchange Commission. Many of the
factors that will determine our future results are beyond our ability to
control or predict. In light of the significant uncertainties inherent
in the forward-looking statements contained herein, readers should not
place undue reliance on forward-looking statements, which reflect
management’s views only as of the date hereof. We undertake no
obligation to revise or update any forward-looking statements, or to
make any other forward-looking statements, whether as a result of new
information, future events or otherwise.
All references to “Company” and “HCA” as used throughout this release
refer to HCA Holdings, Inc. and its affiliates.
HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
or
Media Contact:
Ed Fishbough, 615-344-2810